ArticleAntibodies (Basel, Switzerland)2026

A CSF-1R Ig4-5 Domain-Targeting Antibody for the Treatment of Idiopathic Pulmonary Fibrosis.

Wusong Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.